Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 3/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | APEX1 | P27695 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | RAB9A | P51151 | 3/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 5/20 | 0.32 |
| ▸ | PPARG | P37231 | 4/20 | 0.32 |
| ▸ | PPARD | Q03181 | 4/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7626546 | 0.95 | POLB (0.39) | POLBTDP1HTTAPEX1NPC1 | |
| SCHEMBL7624134 | 0.89 | SMN1; SMN2 (0.33) | POLBTDP1HTTAPEX1MAPT | |
| SCHEMBL3367989 | 0.88 | PPARA (0.42) | POLBTDP1HTTAPEX1NPC1 | |
| SCHEMBL7631080 | 0.87 | PPARA (0.41) | POLBTDP1HTTAPEX1ALDH1A1 | |
| SCHEMBL7629965 | 0.87 | CYP1A2 (0.40) | POLBTDP1HTTAPEX1NPC1 | |
| SCHEMBL7627025 | 0.84 | PPARA (0.41) | POLBTDP1HTTAPEX1NPC1 | |
| SCHEMBL7627000 | 0.84 | HTT (0.33) | POLBTDP1HTTAPEX1NPC1 | |
| SCHEMBL3372532 | 0.83 | PPARA (0.44) | POLBTDP1HTTAPEX1NPC1 | |
| SCHEMBL7629752 | 0.83 | POLB (0.45) | POLBTDP1HTTAPEX1NPC1 | |
| SCHEMBL7626454 | 0.83 | CES2 (0.36) | POLBTDP1HTTAPEX1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020077316-A1 | Sulfide and disulfide compounds and compositions for cholesterol management and related uses | ESPERION THERAPEUTICS, INC. | 2002-06-20 | — | — | US | claimed |
| US-6242551-B1 | SUCH AS CONTACT LENSES, INTRAOCULAR LENSES, AND ARTIFICIAL CORNEA; REDUCES SEPARATION OR ELUTION, CHEMICALLY STABLE, AND DOES NOT DENATURE UNDER HYDROLYSIS; MAINTAINS ORIGINAL COLOR TONE | MENICON CO., LTD. (JP) | 2001-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020077316-A1 | Sulfide and disulfide compounds and compositions for cholesterol management and related uses | GSS, IAPP, STS | POLB 4743/4885TDP1 3733/4885HTT 2167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.